scholarly article | Q13442814 |
P50 | author | Françoise Barré-Sinoussi | Q103844 |
Cristian Apetrei | Q57442625 | ||
Ivona Pandrea | Q89432839 | ||
Ousmane Diop | Q90470460 | ||
Abdourahmane Faye | Q114399064 | ||
Christopher Kornfeld | Q114399067 | ||
Pierre Roques | Q37617950 | ||
Michaela Müller-Trutwin | Q41921596 | ||
P2093 | author name string | Pierre Rouquet | |
François Simon | |||
Mickael J-Y Ploquin | |||
P2860 | cites work | Classic AIDS in a sooty mangabey after an 18-year natural infection | Q24563966 |
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype | Q28646874 | ||
Importance of the nef gene for maintenance of high virus loads and for development of AIDS | Q29618369 | ||
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection | Q29619099 | ||
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma | Q29619980 | ||
Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic | Q30421011 | ||
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication | Q33490135 | ||
Characterization of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses. | Q33640244 | ||
Natural infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus | Q33782096 | ||
Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease | Q33782693 | ||
Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection | Q33793153 | ||
Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus | Q33812785 | ||
Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection. | Q33813926 | ||
Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease | Q33850643 | ||
Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution | Q33854213 | ||
High levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx | Q34348128 | ||
Noninvasive detection of new simian immunodeficiency virus lineages in captive sooty mangabeys: ability to amplify virion RNA from fecal samples correlates with viral load in plasma | Q34467648 | ||
Regulatory genes of simian immunodeficiency viruses from west African green monkeys (Cercopithecus aethiops sabaeus) | Q35851550 | ||
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection | Q35895554 | ||
Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo | Q36109349 | ||
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages | Q36340560 | ||
The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo | Q45768259 | ||
Detection of Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 2 Capsid Antigens by a Monoclonal Antibody-Based Antigen Capture Assay | Q45786811 | ||
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group | Q45832109 | ||
Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). | Q45843205 | ||
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality | Q45844635 | ||
Increase of HIV-1 subtype A in Central African Republic. | Q46336561 | ||
Broad spectrum of coreceptor usage and rapid disease progression in HIV-1-infected individuals from Central African Republic | Q46383565 | ||
Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia | Q47968115 | ||
Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia | Q48023288 | ||
Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon | Q48276837 | ||
Hybrid origin of SIV in chimpanzees. | Q52842327 | ||
Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. | Q52843609 | ||
Immunodeficiency and Lymphoproliferative Disease in an African Green Monkey Dually Infected with SIV and STLV-I | Q53851608 | ||
High levels of SIVmnd-1 replication in chronically infected Mandrillus sphinx | Q56838018 | ||
Chronic SIV infection ultimately causes immunodeficiency in African non-human primates | Q56838029 | ||
HIV with multiple gene deletions as a live attenuated vaccine for AIDS | Q67967865 | ||
Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. | Q36401180 | ||
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection | Q36548993 | ||
Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild | Q36638381 | ||
Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys. | Q36642795 | ||
Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant | Q36645006 | ||
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac | Q36653572 | ||
Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque | Q36656211 | ||
Species-specific diversity among simian immunodeficiency viruses from African green monkeys | Q36692679 | ||
DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm | Q36942836 | ||
Direct inoculation of simian immunodeficiency virus from sooty mangabeys in black mangabeys (Lophocebus aterrimus): first evidence of AIDS in a heterologous African species and different pathologic outcomes of experimental infection | Q37583448 | ||
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys | Q37633735 | ||
Identification of a new subgroup of SIVagm in tantalus monkeys | Q38889785 | ||
Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes. | Q39154687 | ||
Coreceptor Switch of [MLV(SIVagm)] pseudotype vectors by V3-loop exchange. | Q39488538 | ||
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. | Q39551934 | ||
The U3 promoter and the nef gene of simian immunodeficiency virus (SIV) smmPBj1.9 do not confer acute pathogenicity upon SIVagm | Q39579608 | ||
Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. | Q39582896 | ||
A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques | Q39583691 | ||
Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo | Q39588498 | ||
High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys | Q39592712 | ||
Identification of highly attenuated mutants of simian immunodeficiency virus | Q39642374 | ||
Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. | Q39877649 | ||
Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression. | Q40041966 | ||
Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection | Q40715164 | ||
Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host | Q41025176 | ||
Identification of V3 mutations that can compensate for inactivating mutations in C4 of simian immunodeficiency virus | Q41281770 | ||
Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria | Q42692037 | ||
Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection | Q43702789 | ||
Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein | Q44292825 | ||
Age-dependent changes in T cell homeostasis and SIV load in sooty mangabeys | Q44384011 | ||
Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees | Q45734966 | ||
Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor | Q45737136 | ||
The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques. | Q45741951 | ||
Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5. | Q45746519 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Simian immunodeficiency virus | Q1890246 |
P304 | page(s) | 6249-6259 | |
P577 | publication date | 2005-05-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys | |
P478 | volume | 79 |
Q36631943 | Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence |
Q89972347 | African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity |
Q28552448 | Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques |
Q39141518 | CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections. |
Q34647722 | Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys. |
Q37834099 | Coreceptor use in nonhuman primate models of HIV infection |
Q35973670 | Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues |
Q37224358 | Cutting edge: Experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion |
Q37356010 | Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4. |
Q33872468 | Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication |
Q37365356 | Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host |
Q35982025 | Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection |
Q33888012 | Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication |
Q34315105 | Expression sequence tag library derived from peripheral blood mononuclear cells of the chlorocebus sabaeus |
Q33602718 | Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild |
Q33987485 | Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion |
Q34290999 | Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys |
Q31066870 | Going wild: lessons from naturally occurring T-lymphotropic lentiviruses |
Q35599278 | Immunovirological analyses of chronically simian immunodeficiency virus SIVmnd-1- and SIVmnd-2-infected mandrills (Mandrillus sphinx). |
Q27324621 | Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection |
Q33733411 | Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts |
Q40497275 | Isolation of a simian immunodeficiency virus from a malbrouck (Chlorocebus cynosuros). |
Q27333255 | Kinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infections |
Q46976694 | Long oligonucleotide microarrays for African green monkey gene expression profile analysis |
Q35868061 | Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites |
Q57095865 | Natural SIV Infection |
Q33743884 | Pathogenic features associated with increased virulence upon Simian immunodeficiency virus cross-species transmission from natural hosts |
Q34181830 | Pattern of SIVagm infection in patas monkeys suggests that host adaptation to simian immunodeficiency virus infection may result in resistance to infection and virus extinction |
Q36673279 | Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding |
Q35616028 | Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts |
Q34545626 | Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx). |
Q37800574 | SIV infection in natural hosts: resolution of immune activation during the acute-to-chronic transition phase |
Q27340281 | SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations |
Q36736843 | Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors |
Q35641175 | Simian Immunodeficiency Virus SIVsab Infection of Rhesus Macaques as a Model of Complete Immunological Suppression with Persistent Reservoirs of Replication-Competent Virus: Implications for Cure Research |
Q36974698 | Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagm. |
Q36498208 | Simian immunodeficiency virus SIVagm dynamics in African green monkeys |
Q34647780 | Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts |
Q37275075 | Simian immunodeficiency virus SIVrcm, a unique CCR2-tropic virus, selectively depletes memory CD4+ T cells in pigtailed macaques through expanded coreceptor usage in vivo |
Q50721334 | Simian immunodeficiency viruses replication dynamics in African non-human primate hosts: common patterns and species-specific differences. |
Q55605404 | Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage. |
Q58395217 | The Evolution of Resistance to Simian Immunodeficiency Virus (SIV): A Review |
Q40619853 | The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression |
Q27318045 | Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization |
Q37738146 | Where the wild things are: pathogenesis of SIV infection in African nonhuman primate hosts |
Search more.